Body mass index negatively regulates glycated albumin through insulin secretion in patients with type 2 diabetes mellitus

Clinica Chimica Acta

Volumn 438, Issue , 2015, Pages 19-23

  Koga, Masafumi ^a   Hirata, Takumi ^b   Kasayama, Soji ^c   Ishizaka, Yuko ^d   Yamakado, Minoru ^d  

^a Kawanishi City Hospital   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c Nissay Hospital   (Japan)

^d MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Body mass index; Glycated albumin; HbA1c; Insulin secretion; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; GLYCOSYLATED ALBUMIN; INSULIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY MASS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; AGED; METABOLISM; MIDDLE AGED; SECRETION (PROCESS); B LYMPHOCYTE; BIOLOGICAL MODEL; CELL FUNCTION; CHRONIC INFLAMMATION; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT FOR BETA CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; REGULATORY MECHANISM;

AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 84906335997     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.035     Document Type: Article

References (30)

1. Cohen M.P. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?. J Diabet Complications 1988, 2:214-217.
2. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976, 295:417-420.
3. Bunn H.F., Gabbay K.H., Gallop P.M. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978, 20:21-27.
4. Koga M., Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010, 57:751-762.
5. Koga M., Murai J., Saito H., Mukai M., Matsumoto S., Kasayama S. Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects. Ann Clin Biochem 2010, 47:39-43.
6. Yoshiuchi K., Matsuhisa M., Katakami N., et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008, 55:503-507.
7. Koga M., Murai J., Saito H., Kasayama S. Glycated albumin and glycated hemoglobin are differently influenced by endogeneous insulin secretion in patients with type 2 diabetes mellitus. Diabetes Care 2010, 33:270-272.
8. Suwa T., Ohta A., Matsui T., et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J 2010, 57:135-140.
9. Di Flaviani A., Picconi F., Di Stefano P., et al. Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 2011, 34:1605-1609.
10. Arvangat A.V., Gerich J.E. Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk. Vasc Health Risk Manag 2010, 24:145-155.
11. Nishimura R., Kanda A., Sano H., et al. Glycated albumin is low in obese, non-diabetic children. Diabetes Res Clin Pract 2006, 71:334-338.
12. Koga M., Matsumoto S., Saito H., Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 2006, 53:387-391.
13. Miyashita Y., Nishimura R., Morimoto A., Matsudaira T., Sano H., Tajima N. Glycated albumin is low in obese, type 2 diabetic patients. Diabetes Res Clin Pract 2007, 78:51-55.
14. Koga M., Otsuki M., Matsumoto S., Saito H., Mukai M., Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chem Acta 2007, 378:48-52.
15. Bulló M., Garcia-Lorda P., Megias I., Salas-Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003, 11:525-531.
16. Das I. Raised C-reactive protein levels in serum from smokers. Clin Chem Acta 1985, 153:9-13.
17. The International Expert Committee International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
18. Motomura T., Okamoto M., Kitamura T., et al. Effects of pitavastatin on serum lipids and C-reactive protein in type 2 diabetic patients. J Atheroscler Thromb 2009, 16:546-552.
19. Kashiwagi A., Kasuga M., Araki E., et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012, 3:8-10.
20. Kouzuma T., Usami T., Yamakoshi M., Takahashi M., Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2002, 324:61-71.
21. Hashimoto K., Kasayama S., Yamamoto H., Kurebayashi S., Kawase I., Koga M. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med 2004, 21:581-585.
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Kitamura T., Otsuki M., Tamada D., et al. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome. Clin Chim Acta 2013, 424:164-167.
24. Okada T., Nakao T., Matsumoto H., et al. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med 2011, 50:23-29.
25. Funakoshi S., Fujimoto S., Hamasaki A., et al. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract 2008, 82:353-358.
26. Yoon K.H., Ko S.H., Cho J.H., et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003, 88:2300-2308.
27. Ogawa A., Hayashi A., Kishihara E., Yoshino S., Takeuchi A., Shichiri M. New indices for predicting glycaemic variability. PLoS One 2012, 7:e46517.
28. Saisho Y., Tanaka K., Abe T., Shimada A., Kawai T., Itoh H. Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes. Diabetol Int 2011, 2:146-153.
29. Kim D., Kim K.J., Huh J.H., et al. The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol (Oxf) 2012, 77:679-683.
30. Koga M., Murai J., Saito H., Mukai M., Kasayama S. Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in hyperuricemic men. Acta Diabetol 2010, 47:173-177.